全文获取类型
收费全文 | 5005篇 |
免费 | 270篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 18篇 |
儿科学 | 164篇 |
妇产科学 | 166篇 |
基础医学 | 813篇 |
口腔科学 | 76篇 |
临床医学 | 421篇 |
内科学 | 862篇 |
皮肤病学 | 107篇 |
神经病学 | 545篇 |
特种医学 | 155篇 |
外科学 | 394篇 |
综合类 | 58篇 |
预防医学 | 480篇 |
眼科学 | 285篇 |
药学 | 403篇 |
中国医学 | 8篇 |
肿瘤学 | 330篇 |
出版年
2023年 | 19篇 |
2022年 | 58篇 |
2021年 | 81篇 |
2020年 | 45篇 |
2019年 | 70篇 |
2018年 | 94篇 |
2017年 | 55篇 |
2016年 | 108篇 |
2015年 | 121篇 |
2014年 | 148篇 |
2013年 | 197篇 |
2012年 | 324篇 |
2011年 | 391篇 |
2010年 | 195篇 |
2009年 | 189篇 |
2008年 | 337篇 |
2007年 | 314篇 |
2006年 | 331篇 |
2005年 | 330篇 |
2004年 | 292篇 |
2003年 | 257篇 |
2002年 | 283篇 |
2001年 | 48篇 |
2000年 | 29篇 |
1999年 | 66篇 |
1998年 | 89篇 |
1997年 | 77篇 |
1996年 | 57篇 |
1995年 | 48篇 |
1994年 | 45篇 |
1993年 | 42篇 |
1992年 | 35篇 |
1991年 | 24篇 |
1990年 | 18篇 |
1989年 | 14篇 |
1988年 | 35篇 |
1987年 | 19篇 |
1986年 | 24篇 |
1985年 | 24篇 |
1984年 | 21篇 |
1983年 | 19篇 |
1982年 | 17篇 |
1981年 | 15篇 |
1980年 | 18篇 |
1979年 | 14篇 |
1978年 | 15篇 |
1977年 | 14篇 |
1974年 | 14篇 |
1964年 | 13篇 |
1962年 | 13篇 |
排序方式: 共有5285条查询结果,搜索用时 31 毫秒
71.
Lechoslaw Turski Ursula Havemann Klaus Kuschinsky 《Naunyn-Schmiedeberg's archives of pharmacology》1984,327(1):14-17
Summary Bethanechol chloride (5–25 g), when injected into the substantia nigra pars reticulata (SNR) of rats, produced muscular rigidity in a dose-dependent way, and in addition, catalepsy and ipsilateral posture. The effects of bethanechol in the dose of 25 g were prevented by coadministration of 10 g scopolamine hydrochloride. Injections of 25 g betanechol or 10 g scopolamine into the reticulata only slightly affected the muscular rigiditiy produced by 15 mg/kg i.p. morphine hydrochloride. The results suggest that muscarinic cholinergic mechanisms in the substantia nigra pars reticulata, although effective by themselves, affect by expression of at least one striatal functional alteration, the muscular rigidity, in a less effective way than GABAergic or endogenous opioid mechanisms do. 相似文献
72.
Kainz Elena Stuff Karin Kahl Ursula Wiessner Christian Yu Yuanyuan von Breunig Franziska Nitzschke Rainer Haese Alexander Graefen Markus Fischer Marlene 《Quality of life research》2022,31(8):2397-2410
Quality of Life Research - The objective of this study was to determine the influence of postanesthesia care unit (PACU) delirium on self-reported cognitive function and perceived health... 相似文献
73.
Ursula Thiem Veronika Buxhofer-Ausch Wolfgang Kranewitter Gerald Webersinke Wolfgang Enkner Daniel Cejka 《American journal of transplantation》2021,21(1):405-409
Active malignancy is an absolute contraindication to kidney transplantation. As for chronic myeloid leukemia (CML), a Philadelphia chromosome-positive myeloproliferative neoplasm, the introduction of tyrosine kinase inhibitors has transformed CML from a lethal into a manageable chronic disease with a close-to-normal life expectancy. To date it is unknown whether kidney transplantation can be safely performed in patients with pre-existing CML. We describe the clinical course of a 57-year-old male patient with chronic kidney disease caused by reflux nephropathy. This patient had undergone first kidney transplantation 20 years earlier and had again been on chronic hemodialysis for 6 years when CML was diagnosed. First-line therapy with 400 mg imatinib daily was well tolerated and induced an optimal cytogenetic and molecular response 3 months after initiation. One and a half years after CML diagnosis, a second kidney transplantation from a deceased donor was performed. Immunosuppression included basiliximab, tacrolimus, mycophenolate mofetil, and corticosteroids. Currently, 2 years posttransplant, renal allograft function is stable (serum creatinine 1.09 mg/dL, estimated glomerular filtration rate 75 mL/min per 1.73 m2), and CML remains in deep molecular remission with imatinib. Imatinib-treated CML in deep molecular remission could be regarded as inactive malignancy and may therefore not be viewed as an absolute contraindication to kidney transplantation. 相似文献
74.
Tancevski I Frank S Massoner P Stanzl U Schgoer W Wehinger A Fievet C Eller P Patsch JR Ritsch A 《Journal of molecular medicine (Berlin, Germany)》2005,83(11):927-932
Scavenger receptor class B type I (SR-BI), a CD36 family member, plays a key role in high-density lipoprotein (HDL) metabolism, reverse cholesterol transport, and whole body cholesterol homeostasis, and is shown to be involved in the development of atherosclerosis in mice. In this report, we describe the effects of the adenoviral overexpression of human SR-BI (hSR-BI) in New Zealand White (NZW) rabbits, a wild-type animal model that expresses cholesteryl ester transfer protein (CETP) in plasma, displays a manlike lipoprotein profile, and is susceptible to atherosclerosis. A total of 1×1012 adenoviral particles containing either hSR-BI or lacZ complementary deoxyribonucleic acid (control) were infused into the ear vein of NZW rabbits. Transgene expression was ascertained by TaqMan Real Time polymerase chain reaction measurements. Rabbits infected with Ad/hSR-BI (adenoviral plasmids containing hSR-BI) showed a faster clearance of administered [3H]HDL cholesterol and significantly decreased apolipoprotein (apo) A-I levels when compared to control rabbits, respectively. Interestingly, we found markedly increased levels of low-density lipoprotein (LDL) cholesterol exclusively in SR-BI-overexpressing rabbits. These changes were not accompanied by alterations in LDL receptor expression but by increased levels of CE transfer in these animals. By lowering HDL cholesterol and increasing plasma apoB-containing lipoprotein levels, the overexpression of SR-BI leads to a lipoprotein pattern, which is believed to enhance the development of atherosclerosis. The role of SR-BI in lipoprotein metabolism and atherogenesis in rabbits—a CETP-expressing animal model displaying a manlike lipoprotein profile—may therefore be different from the one found in rodents. 相似文献
75.
The Flow-Fluorescence Cytometric Method (FCM) was applied to investigate the DNA content and the ploidy outlines of each of 96 glioblastomas. No specific DNA pattern was detected, possibly because of the tangle morphology of these variable tumors. Due to their capricious growth the DNA distribution proved to fluctuate greatly. Thus, the series, arranged according to increased PI (proliferation index) values, exhibited a wide spread within a total range from 7.1–97.15% (mean 39.3%) PI. A threefold subdivision of main types (I–III) appears to be of practical use for clinical prognostic assessment: diploid tumors with a PI range up to 10% (N=7) are followed by abnormal chiefly tretra- and hyper-tetraploid tumors up to PI values about 30% (N=21). The third category includes cases showing excessive aneuploidy combined more and more with polyploidy and valid stemlines, up to the PI maximum of about 97 rel.% (N=68). Thus, in 89 tumors clear pathological changes of DNA content can be decoded; of these 68 (76.4%) express a considerable aneuploidy and polyploidy respectively.Dedicated to Prof. Dr. HJ Bauer for his 75th birthday, March 31, 1989 相似文献
76.
Abdullahi Idris Nasir Lozano Carmen Juárez-Fernández Guillermo Höfle Ursula Simón Carmen Rueda Silvia Martínez Angela Álvarez-Martínez Sandra Eguizábal Paula Martínez-Cámara Beatriz Zarazaga Myriam Torres Carmen 《European journal of clinical microbiology & infectious diseases》2023,42(5):569-581
European Journal of Clinical Microbiology & Infectious Diseases - This study determined the carriage rates and antimicrobial resistance (AMR) genes of enterococci from... 相似文献
77.
4-Phenyl-1-(4-phenylbutyl)piperidine(4-PPBP) is a very potent ligand for σ (Sigma) receptors. The present study was undertaken to evaluate [3H]4-PPBPas a radioligand for in vivo labeling of cerebral σ receptors. After intravenous administration of [3H]4-PPBP to mice, there is high uptake of radioactivity in the brain. The regional distribution of radioactivity in the brain 2 h after intravenous injection of [3H]4-PPBP parallels the in vitro binding of the radioligand in rat brain (pons/medulla > cerebellum ≥ prefrontal cortex ≥ parietal cortex > hypothalamus > olfactory tubercle ≥ thalamus > hippocampus > striatum). Pretreatment with haloperidol (2 mg/kg) significantly decreases the radioactivity measured in the brain 30–120 min after injection of [3H]4-PPBP. Pretreatment with unlabeled 4-PPBP or ifenprodil also significantly decreases radioactivity in the brain 2 h after injection of [3H]4-PPBP, in a dosedependent manner. The in vivo binding of [3H]4-PPBP in the brain also is significantly inhibited by SL 82.0715, BMY 14802, 1,3-di-o-tolylguanidine (DTG), and (+)-enantiomers of pentazocine, SKF 10,047, and 3-PPP, but not by the corresponding (?)-enantiomers, consistent with stereoselectivity of inhibition obtained in in vitro binding studies. In contrast, pretreatment with dizocilpine and spiperone does not inhibit in vivo binding of [3H]4-PPBP. The results indicate that [3H]4-PPBP would be a suitable radioligand for in vivo labeling of σ receptors in brain. © 1995 Wiley-Liss, Inc. 1 This article is a US Government work and, as such, is in the public domain in the United States of America . 相似文献
78.
79.
The ultrastructure of parapapillary chorioretinal atrophy in eyes with secondary angle closure glaucoma 总被引:4,自引:0,他引:4
Toshiaki Kubota Ursula M. Schlötzer-Schrehardt Gottfried O. H. Naumann Toshihiko Kohno Hajime Inomata 《Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie》1996,234(6):351-358
Background: The present study was performed to investigate the ultrastructure of deep retinal layers and choroid corresponding to the parapapillary chorioretinal atrophy in eyes with secondary angle-closure glaucoma. Methods: The glaucomatous eyes included two eyes enucleated due to iris ring melanoma with high intraocular pressure and one eye with neovascular glaucoma enucleated due to ocular pain. The control eyes included one eye enucleated due to choroidal malignant melanoma with normal intraocular pressure and one eye enucleated during surgery for supramandibular carcinoma. These eyes were studied with light and electron microscopy. Results: In the region of parapapillary chorioretinal atrophy of glaucomatous eyes, the retinal pigment epithelial cells showed degenerative changes, such as loss of basal in foldings and microvilli, degenerated mitochondria, vacuolar degeneration and irregular distribution of melanin granules. The photoreceptors were decreased in number in this area of glaucomatous eyes. The lumen of the choriocapillary vessels adjacent to the optic nerve was collapsed. Conclusion: These results elucidate the fine structures of deep retina and choroid in the region of parapapillary chorioretinal atrophy of glaucomatous eyes, and suggest that the reduced choroidal perfusion might be the pathogenetic mechanism of glaucomatous parapapillary chorioretinal atrophy. 相似文献
80.
Christian M. Kurbacher Ian A. Cree Ursula Brenne Howard W. Bruckner Jutta A. Kurbacher Peter Mallmann Peter E. Andreotti Dieter Krebs 《Breast cancer research and treatment》1996,41(2):161-170
Summary Apart from clinical trials, mitoxantrone (MX) is rarely used in breast cancer (BC) due to the anticipated anthracycline cross-resistance. We have examined this drug versus doxorubicin (DOX) using data obtained fromin vitro microplate ATP tumor chemosensitivity assays (ATP-TCA) of BC cells which were derived from 55 chemotherapy-naive patients at time of primary surgery. Both drugs were tested at 6 different concentrations ranging from 6.25% to 200% peak plasma concentrationin vivo (PPC). Differences between DOX and MX observed for mean IC50, IC90, and a sensitivity index (SI) were not statistically significant.In vitro response rates were 44% for DOX and 52% for MX. 34 of 52 eligible assays (65%) showed comparable activity of both drugs whereas a lack of cross-resistance was observed in the remaining 18 (35%) tumors as indicated by differences for SI. Cumulative concentration-response plots of tumors respondingin vitro with a 50 percent or 90 percent tumor cell inhibition showed a strong dose-dependence for both DOX and MX at concentrations which normally can be achieved within clinical tumors (i.e. 6.25%-50% PPC). At higher concentrations, however, cytotoxicity of DOX and MX could not be improved by furtherin vitro dose escalation. Moreover, a substantial proportion of BC specimens (DOX: 48.1%; MX: 40.4%) did not experience a 90 tumor cell inhibition at 200% PPC. In conclusion,in vitro results obtained by ATP-TCA indicate that there is no cross-resistance between MX and DOX in a substantial proportion of BC patients. This may be clinically useful and suggests that combinations including MX should be tested in patients clinically resistant to DOX containing regimens. Since both drugs produced sigmoidal concentration-response curves, dose escalation beyond a certain point may not produce increased sensitivity. 相似文献